Daejeon, South Korea

Myung Ho Kor

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Incospharm Corporation. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myung Ho Kor. Retrieved from https://idiyas.com/inventor/myung-ho-kor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Myung Ho Kor: Innovator in Autophagy Activation Compounds

Introduction

Myung Ho Kor is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicinal and cosmetic compositions, particularly focusing on autophagy activation. With a total of four patents to his name, Kor is recognized for his innovative approaches to treating various skin conditions and diseases.

Latest Patents

Kor's latest patents include a groundbreaking autophagy activation-induced compound aimed at improving skin inflammation associated with aging. This invention provides a novel compound or its salt, which can be used in medicinal compositions for the treatment and prevention of neurodegenerative diseases, type II diabetes, and skin conditions such as atopy or psoriasis dermatitis. Additionally, he has developed a cosmetic composition designed to alleviate aging and skin disorders, as well as a food composition that incorporates the autophagy-inducing compound.

Another notable patent involves a novel compound that contributes to a cosmetic composition for skin whitening. This pharmaceutical composition is intended for preventing and treating melanin hyperpigmentation disorders by activating autophagy to induce melanosome degradation. It effectively inhibits the endocytosis of keratinocytes, thereby improving and preventing hyperpigmentation disorders caused by melanin.

Career Highlights

Myung Ho Kor is currently associated with Incospharm Corporation, where he continues to innovate in the field of skin health and disease prevention. His work has garnered attention for its potential applications in both medical and cosmetic industries.

Collaborations

Kor collaborates with notable colleagues, including Heung Jae Kim and Seok Jeong Yoon, who contribute to his research and development efforts. Their combined expertise enhances the potential impact of their innovations.

Conclusion

Myung Ho Kor stands out as a leading inventor in the realm of autophagy activation compounds, with a focus on improving skin health and treating various diseases. His contributions are paving the way for advancements in both medicinal and cosmetic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…